Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ticagrelor reduces thrombus formation more than clopidogrel, even when co-administered with bivalirudin.

× No keyword cloud information.

8 in total

1. Antithrombotic effects of DX-9065a, a direct factor Xa inhibitor: a comparative study in humans versus low molecular weight heparin.

Authors: Daichi Shimbo; Julio Osende; Julie Chen; Jonathan Robbins; Yoshimasa Shimoto; Satoshi Kunitada; Valentin Fuster; Juan Jose Badimon
Journal: Thromb Haemost Date: 2002-11 Impact factor: 5.249

2. Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study.

Authors: Paul A Gurbel; Kevin P Bliden; Waiel Samara; Jason A Yoho; Kevin Hayes; Mulugeta Z Fissha; Udaya S Tantry
Journal: J Am Coll Cardiol Date: 2005-10-19 Impact factor: 24.094

3. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study.

Authors: Paul A Gurbel; Kevin P Bliden; Kathleen Butler; Udaya S Tantry; Tania Gesheff; Cheryl Wei; Renli Teng; Mark J Antonino; Shankar B Patil; Arun Karunakaran; Dean J Kereiakes; Cordel Parris; Drew Purdy; Vance Wilson; Gary S Ledley; Robert F Storey
Journal: Circulation Date: 2009-11-18 Impact factor: 29.690

4. Bivalirudin during primary PCI in acute myocardial infarction.

Authors: Gregg W Stone; Bernhard Witzenbichler; Giulio Guagliumi; Jan Z Peruga; Bruce R Brodie; Dariusz Dudek; Ran Kornowski; Franz Hartmann; Bernard J Gersh; Stuart J Pocock; George Dangas; S Chiu Wong; Ajay J Kirtane; Helen Parise; Roxana Mehran
Journal: N Engl J Med Date: 2008-05-22 Impact factor: 91.245

5. A new oral antiplatelet agent with potent antithrombotic properties: comparison of DZ-697b with clopidogrel a randomised phase I study.

Authors: M Urooj Zafar; Borja Ibáñez; Brian G Choi; David A Vorchheimer; Antonio Piñero; Xiaoping Jin; Raman K Sharma; Juan J Badimon
Journal: Thromb Haemost Date: 2009-10-26 Impact factor: 5.249

6. Anti-thrombotic effect of bivalirudin compared with eptifibatide and unfractionated heparin in diabetic patients: an ex vivo human study.

Authors: Eli I Lev; Rajnikant Patel; Azim Karim; Amanda Kleiman; Juan J Badimon; Neal S Kleiman
Journal: Thromb Haemost Date: 2006-03 Impact factor: 5.249

7. Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.

Authors: George Dangas; Roxana Mehran; Giulio Guagliumi; Adriano Caixeta; Bernhard Witzenbichler; Jiro Aoki; Jan Z Peruga; Bruce R Brodie; Dariusz Dudek; Ran Kornowski; LeRoy E Rabbani; Helen Parise; Gregg W Stone
Journal: J Am Coll Cardiol Date: 2009-10-06 Impact factor: 24.094

8. Antiplatelet effects of aspirin vary with level of P2Y₁₂ receptor blockade supplied by either ticagrelor or prasugrel.

Authors: N S Kirkby; P D M Leadbeater; M V Chan; S Nylander; J A Mitchell; T D Warner
Journal: J Thromb Haemost Date: 2011-10 Impact factor: 5.824

8 in total

1 in total

1. Targeting thrombogenicity and inflammation in chronic HIV infection.

Authors: Meagan P O'Brien; M Urooj Zafar; Jose C Rodriguez; Ibeawuchi Okoroafor; Alex Heyison; Karen Cavanagh; Gabriela Rodriguez-Caprio; Alan Weinberg; Gines Escolar; Judith A Aberg; Juan J Badimon
Journal: Sci Adv Date: 2019-06-12 Impact factor: 14.136

1 in total